The DOI matches its Crossref record; 2,264 of the 2,264 references it cites were found in a registry or an index.
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 1,201–1,400 of 2,264
Serotonin-2C and -2a receptor co-expression on cells in the rat medial prefrontal cortex
Nocjar, C., Alex, K. D., Sonneborn, A., Abbas, A. I., Roth, B. L., & Pehek, E. A. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.03.050 · Cited by 84
Self-citationPiñeyro, G. (1995) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00109-q · Cited by 84
Expression of 5‐HT3Areceptors in cells of the immune system
Fiebich, B., Akundi, R., Seidel, M. F., et al. (2004) · Scandinavian Journal of Rheumatology · doi:10.1080/03009740410006952 · Cited by 84
Lowy, M. T., & Meltzer, H. Y. (1988) · Biological Psychiatry · doi:10.1016/0006-3223(88)90070-4 · Cited by 84
Ennis, M. D., Ghazal, N. B., Hoffman, R. L., Smith, M., Schlachter, S. K., Lawson, C., Im, W. B., Pregenzer, J. F., Svensson, K. A., Lewis, R. A., et al. (1998) · Journal of Medicinal Chemistry · doi:10.1021/jm980137o · Cited by 84
Fornal, C. A., Litto, W. J., Metzler, C. W., Marrosu, F., Tada, K., & Jacobs, B. L. (1994) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22545-9 · Cited by 84
Smith, T. K., Park, K. J., & Hennig, G. W. (2014) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm14092 · Cited by 84
Lambe, E. K., Fillman, S. G., Webster, M. J., & Weickert, C. S. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022799 · Cited by 83
Self-citationKleven, M. S., Barret-Grévoz, C., Slot, L. A. B., & Newman‐Tancredi, A. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.02.005 · Cited by 83
Self-citationTerry, A. V., Buccafusco, J. J., Jackson, W. J., Prendergast, M., Fontana, D. J., Wong, E. H. F., Bonhaus, D. W., Weller, P. E., & Eglen, R. M. (1998) · Psychopharmacology · doi:10.1007/s002130050529 · Cited by 83
LP-211 is a brain penetrant selective agonist for the serotonin 5-HT7 receptor
Hedlund, P. B., Leopoldo, M., Caccia, S., Sarkisyan, G., Fracasso, C., Martelli, G., Lacivita, E., Berardi, F., & Perrone, R. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.06.036 · Cited by 83
Self-citationStein, C., Davidowa, H., & Albrecht, D. (2000) · Synapse · doi:10.1002/1098-2396(20001201)38:3<328::aid-syn12>3.0.co;2-t · Cited by 83
Effect of serotonin on the differentiation of human monocytes into dendritic cells
Katoh, N., Soga, F., Nara, T., Tamagawa‐Mineoka, R., Nin, M., Kotani, H., Masuda, K., & Kishimoto, S. (2006) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2006.03197.x · Cited by 83
Sleight, A. J., Stam, N. J., Mutel, V., et al. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02122-1 · Cited by 83
Theisen, F., Hinney, A., Brömel, T., Heinzel‐Gutenbrunner, M., Martin, M., Krieg, J.-C., Remschmidt, H., & Hebebrand, J. (2004) · Psychiatric Genetics · doi:10.1097/00041444-200409000-00003 · Cited by 83
Amrutkar, D. V., Ploug, K. B., Hay‐Schmidt, A., Porreca, F., Olesen, J., & Jansen‐Olesen, I. (2012) · Pain · doi:10.1016/j.pain.2012.01.005 · Cited by 83
Structural basis of ligand recognition in 5‐HT3 receptors
Kesters, D., Thompson, A. J., Brams, M., van Elk, R., Spurný, R., Geitmann, M., Villalgordo, J. M., Guskov, A., Danielson, U. H., Lummis, S. C. R., et al. (2012) · EMBO Reports · doi:10.1038/embor.2012.189 · Cited by 83
Self-citationGene Expression Profiling in Uveal Melanoma: Two Regions on 3p Related to Prognosis
van Gils, W., Lodder, E. M., Mensink, H. W., Kılıç, E., Naus, N. C., Brüggenwirth, H. T., van IJcken, W. F. J., Paridaens, D. A., Luyten, G. P. M., & de Klein, A. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.08-2033 · Cited by 83
The human 5-ht5A receptor couples to Gi/Go proteins and inhibits adenylate cyclase in HEK 293 cells
Francken, B. J. B., Jurzak, M., Vanhauwe, J. F. M., Luyten, W. H. M. L., & Leysen, J. E. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00744-4 · Cited by 83
Flesinoxan lowers blood pressure and heart rate in cats via 5-HT1A receptors
Wouters, W., Tulp, M. T. M., & Bevan, P. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90651-6 · Cited by 83
Sahibzada, N., Ferreira, M. A. R., Wasserman, A. M., Taveira‐DaSilva, A. M., & Gillis, R. A. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35342-x · Cited by 83
Broad, J., Mukherjee, S., Samadi, M., Martin, J., Dukes, G. E., & Sanger, G. J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02009.x · Cited by 82
Self-citationHarada, K., Aota, M., Inoue, T., Matsuda, R., Mihara, T., Yamaji, T., Ishibashi, K., & Matsuoka, N. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.09.042 · Cited by 82
Effect of prucalopride on symptoms of chronic constipation
Tack, J. F., Stanghellini, V., Dubois, D., Joseph, A., Vandeplassche, L. M., & Kerstens, R. (2013) · Neurogastroenterology & Motility · doi:10.1111/nmo.12217 · Cited by 82
Sprouse, J. S. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00057-3 · Cited by 82
Yadav, P. N., Kroeze, W. K., Farrell, M. S., & Roth, B. L. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.183780 · Cited by 82
Self-citationAdayev, T., Ray, I., Sondhi, R., Sobocki, T., & Banerjee, P. (2003) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/s0167-4889(03)00023-5 · Cited by 82
Florian, J. A., & Watts, S. W. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37202-7 · Cited by 82
Self-citationBesson, M., Pelloux, Y., Dilleen, R., Theobald, D. E., Lyon, A., Belin-Rauscent, A., Robbins, T. W., Dalley, J. W., Everitt, B. J., & Belin, D. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.95 · Cited by 81
Cerebral Serotonin 4 Receptors and Amyloid-β in Early Alzheimer's Disease
Madsen, K., Neumann, W., Holst, K. K., Marner, L., Haahr, M. E., Lehel, S., Knudsen, G. M., & Hasselbalch, S. G. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110056 · Cited by 81
Effect of impulsivity on craving and behavioral reactivity to smoking cues
Doran, N., Spring, B. J., & McChargue, D. E. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0832-x · Cited by 81
Martin, C. B. P., Ramond, F., Farrington, D. T., Aguiar, A. S., Chevarin, C., Berthiau, A.-S., Caussanel, S., Lanfumey, L., Herrick‐Davis, K., Hamon, M., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.171 · Cited by 81
Self-citationNapier, C. M., Stewart, M., Melrose, H. L., Hopkins, B., McHarg, A. D., & Wallis, R. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00026-6 · Cited by 81
MacFarlane, P. M., Vinit, S., & Mitchell, G. S. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.01.011 · Cited by 81
Nichols, D. E., Sassano, M. F., Halberstadt, A. L., Klein, L. M., Brandt, S. D., Elliott, S. P., & Fiedler, W. (2014) · ACS Chemical Neuroscience · doi:10.1021/cn500292d · Cited by 81
Self-citationNotes on buspirone's mechanisms of action.
Garattini, S., Caccia, S., & Mennini, T. (1982) · PubMed · Cited by 81
Pitychoutis, P. M., Belmer, A., Moutkine, I., Adrien, J., & Maroteaux, L. (2015) · Neuropsychopharmacology · doi:10.1038/npp.2015.126 · Cited by 80
Self-citationHaub, S., Ritze, Y., Bergheim, I., Pabst, O., Gershon, M. D., & Bischoff, S. C. (2010) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2010.01479.x · Cited by 80
Self-citationSchlenstedt, J., Balfanz, S., Baumann, A., & Blenau, W. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04012.x · Cited by 80
Li, Y., Nie, Y., Xie, J., Tang, W., Liang, P., Sha, W., Yang, H., & Zhou, Y. (2007) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9679-y · Cited by 80
Dunlop, J., Marquis, K. L., Lim, H., Leung, L., Kao, J., Cheesman, C., & Rosenzweig-Lipson, S. J. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2006.00167.x · Cited by 80
5‐HT4 receptor‐mediated modulation of 5‐HT release in the rat hippocampus in vivo
Ge, J., & Barnes, N. M. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb15309.x · Cited by 80
Self-citationLucas, G., & Debonnel, G. (2002) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2002.02150.x · Cited by 80
Shen, C., Li, H., & Meller, E. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00064-3 · Cited by 80
Garrett, S. M., Whitaker, R. M., Beeson, C., & Schnellmann, R. G. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.214700 · Cited by 80
Karaki, S., Bécamel, C., Murat, S., la Cour, C. M., Millan, M. J., Prézeau, L., Bockaert, J., Marin, P., & Vandermoere, F. (2014) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m113.036558 · Cited by 80
Self-citationThe serotonin receptor 7 promotes neurite outgrowth via ERK and Cdk5 signaling pathways
Speranza, L., Chambery, A., Domenico, M. D., Crispino, M., Severino, V., Volpicelli, F., Leopoldo, M., Bellenchi, G. C., di Porzio, U., & Perrone‐Capano, C. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.10.026 · Cited by 80
Self-citationGuseva, D., Holst, K., Kaune, B., Meier, M., Keubler, L. M., Glage, S., Büettner, M., Bleich, A., Pabst, O., Bachmann, O. P., et al. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000150 · Cited by 80
Lorcaserin: A review of its preclinical and clinical pharmacology and therapeutic potential
Higgins, G. A., Fletcher, P. J., & Shanahan, W. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.107417 · Cited by 80
Asada, M., Ebihara, S., Yamanda, S., Niu, K., Okazaki, T., Sora, I., & Arai, H. (2009) · Neoplasia · doi:10.1593/neo.81630 · Cited by 79
Wisden, W., Parker, E. M., Mahle, C. D., Grisel, D. A., Nowak, H. P., Yocca, F. D., Felder, C. C., Seeburg, P. H., & Voigt, M. M. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80368-5 · Cited by 79
Evidence for a Centrally Located Gate in the Pore of a Serotonin-Gated Ion Channel
Panicker, S., Cruz, H. G., Arrabit, C., & Slesinger, P. A. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01629.2002 · Cited by 79
Reeves, D. C., Goren, E. N., Akabas, M. H., & Lummis, S. C. R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106066200 · Cited by 79
Self-citationIneffective erythropoiesis with reduced red blood cell survival in serotonin-deficient mice
Amireault, P., Hatia, S., Bayard, E., Bernex, F., Collet, C., Callebert, J., Launay, J., Hermine, O., Schneider, E., Mallet, J. J., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1103964108 · Cited by 79
Krzywkowski, K., Davies, P. A., Feinberg‐Zadek, P. L., Bräuner‐Osborne, H., & Jensen, A. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708454105 · Cited by 79
Bonaventure, P., Nepomuceno, D. H., Kwok, A. K., Chai, W., Langlois, X., Hen, R., Stark, K. L., Carruthers, N. I., & Lovenberg, T. W. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.240 · Cited by 79
Helton, L. A., Thor, K. B., & Baez, M. (1994) · Neuroreport · doi:10.1097/00001756-199412000-00053 · Cited by 79
Targeting 5-HT1A receptors in astrocytes to protect dopaminergic neurons in parkinsonian models
Miyazaki, I., Asanuma, M., Murakami, S., Takeshima, M., Torigoe, N., Kitamura, Y., & Miyoshi, K. (2013) · Neurobiology of Disease · doi:10.1016/j.nbd.2013.08.003 · Cited by 79
Cdk5, the multifunctional surveyor
Lalioti, V. S., Pulido, D., & Sandoval, I. V. (2010) · Cell Cycle · doi:10.4161/cc.9.2.10466 · Cited by 79
Treatment of apneustic respiratory disturbance with a serotonin-receptor agonist
Wilken, B., Lalley, P. M., Bischoff, A. M., Christen, H. ‐., Behnke‐Mursch, J., Hanefeld, F. A., & Richter, D. W. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70315-9 · Cited by 79
Hoyer, D., & Schoeffter, P. (1988) · European Journal of Pharmacology · doi:10.1016/0014-2999(88)90645-0 · Cited by 79
Self-citationMcLean, S. L., Idris, N. F., Woolley, M. L., & Neill, J. C. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.01.009 · Cited by 79
Dizeyi, N., Bjartell, A. S., Hedlund, P., et al. (2005) · European Urology · doi:10.1016/j.eururo.2005.02.006 · Cited by 79
A Null Mutation of the Serotonin 6 Receptor Alters Acute Responses to Ethanol
Bonasera, S. J., Chu, H.-M., Brennan, T. J., & Tecott, L. H. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301030 · Cited by 79
Interaction of Calmodulin with the Serotonin 5-Hydroxytryptamine2A Receptor
Turner, J. H., & Raymond, J. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501696200 · Cited by 79
5-HT1D receptors in guinea-pig and pigeon brain
Waeber, C., Schoeffter, P., Palacios, J. M., & Hoyer, D. (1989) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00260601 · Cited by 79
Self-citationSerotonin Type 3 Receptor Genes: HTR3A, B, C, D, E
Niesler, B., Kapeller, J., Hammer, C., & Rappold, G. (2008) · Pharmacogenomics · doi:10.2217/14622416.9.5.501 · Cited by 78
The serotonin 5-HT4 receptor and the amyloid precursor protein processing
Lezoualc’h, F. (2003) · Experimental Gerontology · doi:10.1016/s0531-5565(02)00157-2 · Cited by 78
Ion channels gated by acetylcholine and serotonin: structures, biology, and drug discovery
Wu, Z., Cheng, H. D., Jiang, Y., Melcher, K., & Xu, H. E. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.66 · Cited by 78
Intracellular recordings from myenteric neurones in the human colon.
Brookes, S. J., Ewart, W. R., & Wingate, D. L. (1987) · The Journal of Physiology · doi:10.1113/jphysiol.1987.sp016702 · Cited by 78
Mitchell, E. S., Sexton, T. J., & Neumaier, J. F. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301284 · Cited by 78
Self-citationLenglet, S., Louiset, E., Delarue, C., Vaudry, H., & Contesse, V. (2002) · Endocrinology · doi:10.1210/endo.143.5.8817 · Cited by 78
Herrick‐Davis, K., Grinde, E., Lindsley, T. A., Cowan, A. E., & Mazurkiewicz, J. E. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.350249 · Cited by 78
Self-citationPentkowski, N. S., Boynton, F. D. D., Weber, S. M., Pockros, L. A., Teer, A. P., Hamilton, E. C., Thiel, K. J., & Neisewander, J. L. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2010.72 · Cited by 78
Falkenberg, V. R., Gurbaxani, B. M., Unger, E. R., & Rajeevan, M. S. (2010) · NeuroMolecular Medicine · doi:10.1007/s12017-010-8138-2 · Cited by 78
Vilaró, M. T., Domènech, T., Palacios, J. M., & Mengod, G. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00154-x · Cited by 78
Burnet, P. W. J., Chen, C., McGowan, S., Franklin, M., & Harrison, P. J. (1996) · Neuroscience · doi:10.1016/0306-4522(96)00062-0 · Cited by 78
Qiu, J., Xue, C., Bosch, M. A., Murphy, J. G., Fan, W., Rønnekleiv, O. K., & Kelly, M. J. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038083 · Cited by 78
Francis, P. T., Pangalos, M. N., Pearson, R. C. A., Middlemiss, D. N., Stratmann, G. C., & Bowen, D. M. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11149-x · Cited by 78
Excitatory effects of serotonin on rat striatal cholinergic interneurones
Blomeley, C. P., & Bracci, E. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.098269 · Cited by 77
Brattelid, T., Qvigstad, E., Lynham, J. A., Molenaar, P., Aass, H., Geiran, O. R., Skomedal, T., Osnes, J. B., Levy, F. O., & Kaumann, A. (2004) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-004-0963-0 · Cited by 77
Self-citation5-HT1B receptors play a prominent role in the proliferation of T-lymphocytes
Yin, J., Albert, R. H., Tretiakova, A. P., & Jameson, B. A. (2006) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2006.08.004 · Cited by 77
Multiple Regulatory Variants Modulate Expression of 5-Hydroxytryptamine 2A Receptors in Human Cortex
Smith, R. M., Papp, A. C., Webb, A., Ruble, C., Munsie, L. M., Nisenbaum, L. K., Kleinman, J. E., Lipska, B. K., & Sadée, W. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.09.028 · Cited by 77
Galusca, B., Costes, N., Germain, N., Peyron, R., Bossu, C., Lang, F., Bars, D. L., & Estour, B. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.06.006 · Cited by 77
The effects of 5-HT1B characterizing agents in the mouse elevated plus-maze
Benjamin, D., Lal, H., & Meyerson, L. R. (1990) · Life Sciences · doi:10.1016/0024-3205(90)90320-q · Cited by 77
Targeting of the 5-HT1ASerotonin Receptor to Neuronal Dendrites Is Mediated by Yif1B
Carrel, D., Masson, J., Awabdh, S. A., Borg‐Capra, C., Lenkei, Z., Hamon, M., Emerit, M. B., & Darmon, M. C. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4487-07.2008 · Cited by 77
Serotonin Receptor 5-HT2BMediates Serotonin-Induced Mechanical Hyperalgesia
Lin, S.-Y., Chang, W.-J., Lin, C.-S., et al. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.4682-10.2011 · Cited by 77
Zhang, Z., Duan, Z., Wang, L.-X., Yang, D., Zhao, G., & Zhang, L. (2014) · BMC Gastroenterology · doi:10.1186/1471-230x-14-23 · Cited by 77
Expression of Serotonin Receptors in Human Hepatocellular Cancer
Soll, C., Riener, M., Oberkofler, C. E., Hellerbrand, C., Wild, P. J., DeOliveira, M. L., & Clavien, P. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1813 · Cited by 77
Levy, F. O., Gudermann, T. W., Perez‐Reyes, E., Birnbaumer, M. E., Kaumann, A. J., & Birnbaumer, L. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42552-5 · Cited by 76
Self-citationTargeting the 5-HT3 receptor in the treatment of irritable bowel syndrome
Spiller, R. E. (2011) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2011.02.005 · Cited by 76
Characterisation of a cloned human 5-HT1A receptor cell line using [35S]GTPγS binding
Stanton, J. A., & Beer, M. S. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00914-4 · Cited by 76
Anastasio, N. C., Stutz, S. J., Fox, R. G., Sears, R. M., Emeson, R. B., Dileone, R., O’Neil, R. T., Fink, L. H. L., Li, D., Green, T. A., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.199 · Cited by 76
Self-citationHorisawa, T., Ishibashi, T., Nishikawa, H., Enomoto, T., Toma, S., Ishiyama, T., & Taiji, M. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.01.034 · Cited by 76
Distribution of the 5-HT5A serotonin receptor mRNA in the human brain
Pasqualetti, M., Ori, M., Nardi, I., Castagna, M., Cassano, G. B., & Marazziti, D. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00003-5 · Cited by 76
The existence of a local 5‐hydroxytryptaminergic system in peripheral arteries
Ni, W., Geddes, T. J., Priestley, J. R. C., Szasz, T., Kuhn, D. M., & Watts, S. W. (2008) · British Journal of Pharmacology · doi:10.1038/bjp.2008.111 · Cited by 76
Self-citationBerends, A. C., Luiten, P. G. M., & Nyakas, C. J. (2006) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2005.tb00055.x · Cited by 76
Lambe, E. K., & Aghajanian, G. K. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300944 · Cited by 75
Self-citationTao, R., Ma, Z., & Auerbach, S. B. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37608-6 · Cited by 75
Burbassi, S., & Cervo, L. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0916-7 · Cited by 75
Serotoninergic Receptors on Human Airway Epithelial Cells
Bayer, H., Müller, T., Myrtek, D., Sorichter, S., Ziegenhagen, M. W., Norgauer, J., Zissel, G., & Idzko, M. (2006) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2006-0151oc · Cited by 75
Pichon, X., Wattiez, A., Bécamel, C., Ehrlich, I., Bockaert, J., Eschalier, A., Marin, P., & Courteix, C. (2010) · Molecular Therapy · doi:10.1038/mt.2010.101 · Cited by 75
Self-citationSvejda, B., Kidd, M. S., Giovinazzo, F., Eltawil, K. M., Gustafsson, B. I., Pfragner, R., & Modlin, I. M. (2010) · Cancer · doi:10.1002/cncr.25049 · Cited by 75
Peters, J. A., Hales, T. G., & Lambert, J. J. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.09.011 · Cited by 75
Gavarini, S., Bécamel, C., Altier, C., Lory, P., Poncet, J., Wijnholds, J., Bockaert, J., & Marin, P. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-03-0218 · Cited by 75
Self-citationRole of 5-HT receptor mechanisms in sub-chronic PCP-induced reversal learning deficits in the rat
McLean, S. L., Woolley, M. L., Thomas, D. W., & Neill, J. C. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1618-0 · Cited by 74
Implication of 5-HT2B receptors in the serotonin syndrome
Diaz, S. L., & Maroteaux, L. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.01.025 · Cited by 74
Self-citationStructure of the mouse 5-HT 1c 5-HT 2 and stomach fundus serotonin receptor genes
Foguet, M., Nguyen, H., Le, H., & Lübber, H. (1992) · Neuroreport · doi:10.1097/00001756-199204000-00014 · Cited by 74
Zlojutro, M., Manz, N., Rangaswamy, M., Xuei, X., Wetherill, L. F., Koller, D. L., Bierut, L. J., Goate, A., HESSELBROCK, V. M., Kuperman, S., et al. (2010) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.31136 · Cited by 74
Dickson, E. J., Heredia, D. J., & Smith, T. K. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00496.2009 · Cited by 74
Einstein, R., Jordan, H., Zhou, W., Brenner, M., Moses, E. G., & Liggett, S. B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0801319105 · Cited by 74
Evidence that 5-HT2C receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxiety
Kennett, G. A., Pittaway, K. M., & Blackburn, T. P. (1994) · Psychopharmacology · doi:10.1007/bf02245448 · Cited by 74
Somerville, E. M., Horwood, J. M., Lee, M. D., Kennett, G. A., & Clifton, P. G. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05567.x · Cited by 73
El‐Salhy, M., Gundersen, D., Østgaard, H. N., Lomholt-Beck, B., Hatlebakk, J. G., & Hausken, T. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1948-8 · Cited by 73
Wetter, T. C., Lauer, C. J., Gillich, G., & Pollmächer, T. (1996) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(96)00022-2 · Cited by 73
Domènech, T., Beleta, J., & Palacios, J. M. (1997) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/pl00005058 · Cited by 73
Stanford, I. M., Kantaria, M. A., Chahal, H., Loucif, K. C., & Wilson, C. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.09.003 · Cited by 73
Liu, Y., Wei, L., Laskin, D. L., & Fanburg, B. L. (2010) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0078oc · Cited by 73
Mogha, A., Guariglia, S. R., Debata, P. R., Wen, G. Y., & Banerjee, P. (2012) · Translational Psychiatry · doi:10.1038/tp.2011.58 · Cited by 73
Parsons, L. H., KOOB, G. E., & Weiss, F. (1995) · Behavioural Brain Research · doi:10.1016/0166-4328(96)00101-5 · Cited by 73
Huang, M., Panos, J., Kwon, S., Oyamada, Y., Rajagopal, L., & Meltzer, H. Y. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12512 · Cited by 73
Bombardi, C., & Giovanni, G. D. (2013) · Experimental Brain Research · doi:10.1007/s00221-013-3512-6 · Cited by 73
Iderberg, H., McCreary, A. C., Varney, M. A., Cenci, M. A., & Newman‐Tancredi, A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.012 · Cited by 73
Self-citationMcGrew, L., Chang, M. S. S., & Sanders‐Bush, E. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.6.1339 · Cited by 73
RGS inhibition at Gα i2 selectively potentiates 5-HT1A–mediated antidepressant effects
Talbot, J. N., Jutkiewicz, E. M., Graves, S. M., Clemans, C. F., Nicol, M. R., Mortensen, R. M., Huang, X., Neubig, R. R., & Traynor, J. R. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000003107 · Cited by 73
Ponimaskin, E. G., Heine, M., Joubert, L., Sebben, M., Bickmeyer, U., Richter, D. W., & Dumuis, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106529200 · Cited by 73
Role for serotonin2A (5-HT2A) and 2C (5-HT2C) receptors in experimental absence seizures
Venzi, M., David, F., Bellet, J., Cavaccini, A., Bombardi, C., Crunelli, V., & Giovanni, G. D. (2016) · Neuropharmacology · doi:10.1016/j.neuropharm.2016.04.016 · Cited by 73
RNA editing and alternative splicing of human serotonin 2C receptor in schizophrenia
Dracheva, S. M., Elhakem, S. L., Marcus, S. M., Siever, L. J., McGurk, S. R., & Haroutunian, V. H. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02115.x · Cited by 72
Receptor subtype and density determine the coupling repertoire of the 5-ht2 receptor subfamily
Lucaites, V. L., Nelson, D. L. G., Wainscott, D. B., & Baez, M. (1996) · Life Sciences · doi:10.1016/0024-3205(96)00423-7 · Cited by 72
Self-citationExcess of serotonin affects neocortical pyramidal neuron migration
Riccio, O., Jacobshagen, M., Golding, B., Vutskits, L., Jabaudon, D., Hornung, J., & Dayer, A. G. (2011) · Translational Psychiatry · doi:10.1038/tp.2011.49 · Cited by 72
Levy, F. O., Gudermann, T. W., Birnbaumer, M., Kaumann, A. J., & Birnbaumer, L. (1992) · FEBS Letters · doi:10.1016/0014-5793(92)80379-u · Cited by 72
Self-citationThe effect of 5-hydroxytryptamine 3A and 3B receptor genes on nausea induced by paroxetine
Sugai, T., Suzuki, Y., Sawamura, K., Fukui, N., Inoue, Y., & Someya, T. (2006) · The Pharmacogenomics Journal · doi:10.1038/sj.tpj.6500382 · Cited by 72
New and future migraine therapy
Ramadan, N. M., & Buchanan, T. M. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.04.010 · Cited by 72
Serotonergic Regulation of Adrenocortical Function
Lefèbvre, H., Contesse, V., Delarue, C., Vaudry, H., & Kuhn, J. (1998) · Hormone and Metabolic Research · doi:10.1055/s-2007-978904 · Cited by 72
Effect of SB 200646A, a 5-HT2C/5-HT2B receptor antagonist, in two conflict models of anxiety
Kennett, G. A., Bailey, F., Piper, D. C., et al. (1995) · Psychopharmacology · doi:10.1007/bf02245837 · Cited by 72
Deng, P.-Y., & Lei, S. (2008) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2008.07.005 · Cited by 71
Helboe, L., Egebjerg, J., & de Jong, I. E. M. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.09.064 · Cited by 71
SHEPHERD, S. L., WILLIAMSON, D. J., Beer, M. S., Hill, R. G., & Hargreaves, R. J. (1997) · Neuropharmacology · doi:10.1016/s0028-3908(97)00057-9 · Cited by 71
The effect of GR38032F, novel 5‐HT3‐receptor antagonist on gastric emptying in the guinea‐pig
Costall, B., Gunning, S. J., Naylor, R. J., et al. (1987) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1987.tb10280.x · Cited by 71
Monro, R. L., Bornstein, J. C., & Bertrand, P. P. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.05.006 · Cited by 71
Classey, J. D., Bartsch, T., & Goadsby, P. J. (2010) · Brain Research · doi:10.1016/j.brainres.2010.09.004 · Cited by 71
Maekawa, T., Kim, S., Nakai, D., Makino, C., Takagi, T., Ogura, H., Yamada, K., Chatton, B., & Ishii, S. (2009) · The EMBO Journal · doi:10.1038/emboj.2009.318 · Cited by 71
Millan, M. J., Gobert, A., Roux, S., Porsolt, R. D., Meneses, A., Carli, M., Cara, B. D., Jaffard, R., Rivet, J., Lestage, P. J., et al. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.069625 · Cited by 71
On the existence and function of galanin receptor heteromers in the central nervous system
Fuxé, K., Borroto‐Escuela, D. O., Romero‐Fernandez, W., Tarakanov, A. O., Calvo, F., Garriga, P., Tena, M., Narváez, M., Millón, C., Parrado, C., et al. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00127 · Cited by 71
Genetic evaluation of the serotonergic system in chronic fatigue syndrome
Smith, A. K., Dimulescu, I. M., Falkenberg, V. R., Narasimhan, S., Heim, C. C., Vernon, S. D., & Rajeevan, M. S. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.11.001 · Cited by 71
The nucleus accumbens 5-HTR4-CART pathway ties anorexia to hyperactivity
Jean, A., Laurent, L., Bockaert, J., Charnay, Y., Dusticier, N., Nieoullon, A., Barrot, M., Neve, R. L., & Compan, V. (2012) · Translational Psychiatry · doi:10.1038/tp.2012.131 · Cited by 70
Self-citationWestphal, R. S., Backstrom, J. R., & Sanders‐Bush, E. (1995) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)10237-x · Cited by 70
Mocci, G., Jiménez-Sánchez, L., Adell, A., Cortés, R., & Artigas, F. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.10.021 · Cited by 70
Serotonergic 5-HT2C Receptors as a Potential Therapeutic Target for the Design Antiepileptic Drugs
Isaac, M. B. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026053386980 · Cited by 70
Functional characterization of five V2 vasopressin receptor gene mutations
Wenkert, D., Schöneberg, T., Merendino, J. J., Rodríguez-Peña, M. S., Vinitsky, R., Goldsmith, P. K., Wess, J., & Spiegel, A. M. (1996) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(96)03926-3 · Cited by 70
Abdala, A. P., Lioy, D. T., Garg†, S. K., Knopp, S. J., Paton, J. F. R., & Bissonnette, J. M. (2014) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0372oc · Cited by 70
Fletcher, P. J., Rizos, Z., Noble, K., Soko, A. D., Silenieks, L. B., Lê, A. D., & Higgins, G. A. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.023 · Cited by 70
Bézard, E., Gerlach, I., Moratalla, R., Gross, C. E., & Jork, R. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.003 · Cited by 70
The mouse 5-HT1C receptor contains eight hydrophobic domains and is X-linked
Yu, L., Nguyen, H., Le, H., Bloem, L. J., Kozak, C. A., Hoffman, B. J., Snutch, T. P., Lester, H. A., Davidson, N., & Lübbert, H. (1991) · Molecular Brain Research · doi:10.1016/0169-328x(91)90116-f · Cited by 70
Schmid, C. L., Streicher, J. M., Meltzer, H. Y., & Bohn, L. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.38 · Cited by 70
Tan, P., Baldwin, R., van Dyck, C., Al-Tikriti, M., Roth, B. L., Khan, N., Charney, D., & Innis, R. (1999) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(99)00022-0 · Cited by 70
Self-citationAllers, K. A., Dremencov, E., Ceci, A., Flik, G., Ferger, B., Cremers, T. I. F. H., Ittrich, C., & Sommer, B. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01763.x · Cited by 70
Ullmer, C., Boddeke, H. W. G. M., Schmuck, K., & Lübbert, H. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16700.x · Cited by 70
Leopoldo, M., Lacivita, E., Giorgio, P. D., Fracasso, C., Guzzetti, S., Caccia, S., Contino, M., Colabufo, N. A., Berardi, F., & Perrone, R. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800615e · Cited by 70
Self-citationHarvey-Lewis, C., Li, Z., Higgins, G. A., & Fletcher, P. J. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.09.028 · Cited by 70
Noda, M., Yasuda, S., Okada, M., Higashida, H., Shimada, A., Iwata, N., Ozaki, N., Nishikawa, K., Shirasawa, S., Uchida, M., et al. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01518.x · Cited by 69
Veselinović, T., Paulzen, M., & Gründer, G. (2013) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2013.853448 · Cited by 69
Pleiotropic Behavior of 5‐HT2A and 5‐HT2C Receptor Agonists
Berg, K. A., Clarke, W. P., Maayani, S., et al. (1998) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1998.tb10180.x · Cited by 69
Cell Surface Expression of 5-Hydroxytryptamine Type 3 Receptors Is Promoted by RIC-3
Cheng, A., McDonald, N. A., & Connolly, C. N. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414341200 · Cited by 69
[3H]Mesulergine, a selective ligand for serotonin-2 receptors
Closse, A. (1983) · Life Sciences · doi:10.1016/0024-3205(83)90375-2 · Cited by 69
Serotonin Coexists with Epinephrine in Rat Adrenal Medullary Cells
Holzwarth, M. A., & Brownfield, M. S. (2008) · Neuroendocrinology · doi:10.1159/000124182 · Cited by 69
Agonist‐Induced Phosphoinositide Hydrolysis in Choroid Plexus
Conn, P. J., & Sanders‐Bush, E. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb13085.x · Cited by 69
Tzvetkov, M. V., Meineke, C., Oetjen, E., Hirsch‐Ernst, K. I., & Brockmöller, J. (2006) · Gene · doi:10.1016/j.gene.2006.08.002 · Cited by 69
Filippis, B. D., Chiodi, V., Adriani, W., Lacivita, E., Mallozzi, C., Leopoldo, M., Domenici, M. R., Fuso, A., & Laviola, G. (2015) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2015.00086 · Cited by 69
Self-citationFunctional significance of serotonin receptor dimerization
Herrick‐Davis, K. (2013) · Experimental Brain Research · doi:10.1007/s00221-013-3622-1 · Cited by 69
Self-citationHershenson, M. B., Chao, T.-S. O., Abe, M. K., Gomes, I., Kelleher, M. D., Solway, J., & Rosner, M. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.34.19908 · Cited by 69
[3H]-SB-269970 radiolabels 5-HT7 receptors in rodent, pig and primate brain tissues
Thomas, D. R., Atkinson, P. J., Hastie, P. G. R., Roberts, J. C., Middlemiss, D. N., & Price, G. W. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00151-4 · Cited by 69
May, J. A., McLaughlin, M. A., Sharif, N. A., Hellberg, M. R., & Dean, T. R. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.049528 · Cited by 69
Hernández, M. E., Martínez‐Fong, D., Pérez-Tapia, M., Estrada‐García, I., Estrada-Parra, S. A., & Pavón, L. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.11.005 · Cited by 69
Auclair, A. L., Cathala, A., Sarrazin, F., Depoortère, R., Piazza, P. V., Newman‐Tancredi, A., & Spampinato, U. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06848.x · Cited by 69
Self-citationOndansetron reduces nausea induced by gastroduodenal stimulation without changing gastric motility
Feinle, C., & Read, N. W. (1996) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1996.271.4.g591 · Cited by 69
GPCR-Interacting Proteins, Major Players of GPCR Function
Maurice, P., Guillaume, J., Benleulmi‐Chaachoua, A., Daulat, A. M., Kamal, M. T., & Jockers, R. (2011) · Advances in pharmacology · doi:10.1016/b978-0-12-385952-5.00001-4 · Cited by 68
Cellek, S., John, A. K., Thangiah, R., Dass, N. B., Bassil, A. K., Jarvie, E. M., Lalude, O., Vivekanandan, S., & Sanger, G. J. (2006) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00810.x · Cited by 68
Self-citationRodgers, R. J., Holch, P., & Tallett, A. J. (2010) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2010.03.001 · Cited by 68
Morilak, D. A., Somogyi, P., Luján, R., & Ciaranello, R. D. (1994) · Neuropsychopharmacology · doi:10.1038/sj.npp.1380102 · Cited by 68
[3H]DOB: A specific agonist radioligand for 5-HT2 serotonin receptors
Titeler, M., Herrick, K. F., Lyon, R. A., MCKENNEY, J. D. J., & Glennon, R. A. (1985) · European Journal of Pharmacology · doi:10.1016/0014-2999(85)90486-8 · Cited by 68
Roth, B. L., & Ciaranello, R. D. (1991) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(91)90093-w · Cited by 68
Self-citationA comparative study of functional 5‐HT4 receptors in human colon, rat oesophagus and rat ileum
McLean, P. G., Coupar, I. M., & Molenaar, P. (1995) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1995.tb16318.x · Cited by 68
Canal, C. E., Booth, R. G., & Morgan, D. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.01.007 · Cited by 68
Charest, A., Wainer, B., & Albert, P. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-12-05164.1993 · Cited by 68
Villalón, C. M., Centurión, D., Estrada, M. L., Terrón, J. A., & Sánchez‐López, A. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701020 · Cited by 68
Self-citationDifferential 5-HT3mediation of human gastrocolonic response and colonic peristaltic reflex
Bjornsson, E. S., Chey, W. D., Ladabaum, U., Woods, M. L., Hooper, F. G., Owyang, C., & Hasler, W. L. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.275.3.g498 · Cited by 68
Valenti, D., Lidia de, B. A. R. I., Vigli, D., Lacivita, E., Leopoldo, M., Laviola, G., Vacca, R. A., & Filippis, B. D. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.04.024 · Cited by 68
Self-citationGlennon, R. A., Dukat, M., El-Bermawy, M., Law, H., De Los Angeles, J., Teitler, M., King, A., & Herrick-Davis, K. (1994) · Journal of Medicinal Chemistry · doi:10.1021/jm00039a004 · Cited by 67
Self-citationBoothman, L. J., Mitchell, S. N., & Sharp, T. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.11.020 · Cited by 67
Self-citationFyn, a Potential Target for Alzheimer's Disease
Yang, K., Belrose, J. C., Trepanier, C. H., Lei, G., Jackson, M. F., & MacDonald, J. F. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-110353 · Cited by 67
Johnston, K. D., Lu, Z., & Rudd, J. A. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.10.014 · Cited by 67
The role of 5ht2c receptors in affective disorders
Jenck, F., Bös, M., Wichmann, J., Stadler, H., Martin, J. R., & Moreau, J. (1998) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.7.10.1587 · Cited by 67
Bonn, M., Schmitt, A. G., Lesch, K., Bockstaele, E. J. V., & Asan, E. (2012) · Brain Structure and Function · doi:10.1007/s00429-012-0406-5 · Cited by 67
Wöhr, M., Rippberger, H., Schwarting, R. K. W., & van Gaalen, M. M. (2014) · Psychopharmacology · doi:10.1007/s00213-014-3814-9 · Cited by 67
Roberts, C., Thomas, D. R., Bate, S. T., & Kew, J. N. C. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.01.010 · Cited by 67
Dose-related effects of selective 5-HT2 receptor antagonists on slow wave sleep in humans
Sharpley, A. L., Solomon, R. A., Fernando, A. I., Davis, J. M. D. R., & Cowen, P. J. (1990) · Psychopharmacology · doi:10.1007/bf02244239 · Cited by 67
Use of ondansetron in palliative medicine
Currow, D. C., Coughlan, M., Fardell, B., & Cooney, N. J. (1997) · Journal of Pain and Symptom Management · doi:10.1016/s0885-3924(97)00079-1 · Cited by 67
Aira, Z., Buesa, I., Salgueiro, M., Bilbao, J., Aguilera, L., Zimmermann, M., & Azkue, J. J. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.04.032 · Cited by 67
Positive inotropic response to 5-HT in human atrial but not in ventricular heart muscle
Jahnel, U., Rupp, J., Ertl, R., & Nawrath, H. (1992) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/bf00169000 · Cited by 67
Cited by
Tryptophan metabolism and gut-brain homeostasis
Roth, W., Zadeh, K., Vekariya, R., Ge, Y., & Mohamadzadeh, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062973 · Cited by 519
Structural insights into the lipid and ligand regulation of serotonin receptors
Xu, P., Huang, S., Zhang, H., Mao, C., Zhou, X. E., Cheng, X., Simon, I. A., Shen, D.-D., Yen, H.-Y., Robinson, C. V., et al. (2021) · Nature · doi:10.1038/s41586-021-03376-8 · Cited by 270
The neurobiology of social play behaviour: Past, present and future
Achterberg, E. J. M., & Vanderschuren, L. J. M. J. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105319 · Cited by 56
Metadata
- Authors
- Barnes, N. M., Ahern, G. P., Becamel, C., Bockaert, J., Camilleri, M., Chaumont-Dubel, S., Claeysen, S., Cunningham, K. A., Fone, K. C., Gershon, M., Di Giovanni, G., Goodfellow, N. M., Halberstadt, A. L., Hartley, R. M., Hassaine, G., Herrick-Davis, K., Hovius, R., Lacivita, E., Lambe, E. K., Leopoldo, M., Levy, F. O., Lummis, S. C. R., Marin, P., Maroteaux, L., McCreary, A. C., Nelson, D. L., Neumaier, J. F., Newman-Tancredi, A., Nury, H., Roberts, A., Roth, B. L., Roumier, A., Sanger, G. J., Teitler, M., Sharp, T., Villalón, C. M., Vogel, H., Watts, S. W., & Hoyer, D.
- Venue
- Pharmacological Reviews
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 73
- Issue
- 1
- Pages
- 310-520
- ISSN
- 0031-6997 (ISSN-L)
- OpenAlex
- W3116452987
- Cited by
- 263
- References
- 2,264
- FWCI
- 9.06
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.